Combination Chemotherapy With or Without Interleukin-2 and Interferon Alfa in Treating Patients With Metastatic Melanoma

NCT00003027 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

482

Enrollment

NETWORK

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: filgrastim
BIOLOGICAL: recombinant interferon alfa
DRUG: cisplatin
DRUG: dacarbazine
DRUG: vinblastine

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]
[object Object]
[object Object]